Advances in Predictive Biomarkers for Immune Checkpoint Inhibitors in Lung Cancer: Why, Who, and How

Review this CME/MOC-certified program to get up to date on the latest data informing optimal integration of immunotherapy biomarkers into the management of patients with lung cancer, including an on-demand Webcast capturing discussion by medical oncology and pathology experts from a symposium at the 2019 Clinical Pathology meeting and downloadable slidesets.
Hossein Borghaei, MS, DO
Program Director
H. Jack West, MD
Program Director
Joshua Bauml, MD
Sanjay Mukhopadhyay, MD
Sandip P. Patel, MD

Downloadable Slidesets

Download this slideset to review the latest clinical data supporting the optimal use of biomarker testing for checkpoint inhibitor therapy in patients with advanced NSCLC, unresectable stage III NSCLC, or extensive-stage SCLC.

H. Jack West, MD
Program Director
Joshua Bauml, MD Sandip P. Patel, MD
Released: November 5, 2019

Download this slideset to review expert guidance on optimal biomarker testing in lung cancer, including molecular testing by NGS and PD-L1 testing to predict response to checkpoint inhibitor–based therapy.

Sanjay Mukhopadhyay, MD Released: November 5, 2019

Download this slideset to gain expert insights on promising new biomarkers predicting response to checkpoint inhibitors in lung cancer, including thoughts on TMB, MSI, and immunogenic neoantigen burden.

Hossein Borghaei, MS, DO
Program Director
Sandip P. Patel, MD
Released: November 5, 2019

CME/MOC-Certified On-Demand Webcast

Watch this CME/MOC-certified on-demand Webcast of a CCO symposium at ASCP 2019 to gain insights from both medical oncology and pathology experts on the optimal use of predictive biomarkers for immune checkpoint inhibitors in the care of patients with lung cancer.

H. Jack West, MD
Program Director
Sanjay Mukhopadhyay, MD Sandip P. Patel, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: October 8, 2019 Expiration: October 7, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AstraZeneca
Bristol-Myers Squibb
Genentech
Merck Sharp & Dohme Corp

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?